捐赠者和宿主年龄对系统细胞疗法的影响,以治疗与年龄相关的黄斑退化症
Carolina Francelin1, Xiaoping Qi1, Juliana Godoy1,2
1Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Cells
|September 13, 2025
概括
捐赠者和接受者的年龄对治疗视网膜退行症的造血干细胞疗法的成功有重大影响. 在老年接受者中使用老年捐赠细胞带来了最小的益处,这表明与年龄相关的局限性对于治疗诸如与年龄相关的黄斑变性等疾病.
科学领域:
- 眼科医生 眼科 眼科
- 再生医学是一种再生医学.
- 细胞疗法细胞疗法
背景情况:
- 血液造血原生细胞 (HSPCs) 的全身管理显示,对视网膜修复有前途.
- 之前的研究表明,通过HSPC治疗,视觉功能和视网膜色素上皮层 (RPE) 层的恢复得到改善.
研究的目的:
- 调查捐赠者与接受者的年龄对视网膜退行症全身细胞治疗的影响.
- 在小鼠模型中评估RPE65基因编程的HSPCs的疗效.
主要方法:
- 来自年轻和老老小鼠的HSPC被编程为RPE65 (LV-RPE65) 的ex vivo.
- LV-RPE65 HSPCs被系统地给年轻或老的SOD2敲击 (KD) 接受者小鼠.
- 视觉功能和视网膜病理被评估使用电红外图 (ERG),光学连贯性断层扫描 (OCT),组织学和免疫组织化学.
主要成果:
- 在老SOD2KD小鼠中,老供体HSPCs的益处最小,细胞结合减少和视觉功能的改善.
- 在老SOD2KD小鼠中,年轻的供体HSPC提供了一些保护,尽管比年轻宿主少.
- 年轻宿主中的老供体HSPC减少了视力损失,但显示了一些残留病理.
结论:
- 结合老供体细胞和老接受者小鼠的组合,产生了最小的治疗改善.
- 捐赠者和接受者的年龄都是影响基于HSPC的视网膜治疗成功的关键因素.
- 使用老年捐赠细胞治疗与年龄相关的黄斑变性 (AMD) 可能存在局限性.
关键词:
在 RPE65 的情况下,它是 RPE65 的.与年龄相关的黄斑变性.老化的老化 衰老的老化骨髓衍生细胞 骨髓衍生细胞基因治疗的基因疗法造血干细胞 造血干细胞原始人的祖先.视网膜退化 视网膜退化视网膜色素表皮质是视网膜色素表皮质.更多相关视频
相关概念视频
01:22iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
190
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
190
01:19The Effect of Aging on Tissues
3.4K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.4K
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
229
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
229
01:40Cell-mediated Immune Responses
83.5K
Overview
83.5K
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
234
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
234